Anne Engerant Senior Vice President and General Manager LATAM Health of RB
View from the Top
Anne Engerant
Senior Vice President and General Manager LATAM
Health of RB
Together with international institutions and governments, RB Health makes science approachable to improve child nutrition and to promote sex education
Generics
Roundtable
Gurulinga Konanur
Gurulinga Konanur
Director General of Hetero Mexico

There are few API manufacturers in Mexico. As a result, we hold strong ground in Mexico. The quality of a medication relies entirely on the quality of the API. Developing an API requires significantly more investment in R&D than in manufacturing of the finished product. We invest heavily in R&D and we often begin planning them over 10 years before they go off patent. This helps us to offer products to clients at a much more advanced or early stage of product development. We see the biggest competition coming from Asian companies that offer their products at a low price, but they lack great services and speed to reach the market. Hetero has a 500ha chemical complex in Vizag, India that manufactures 24/7, which allows us to offer a high volume of high-quality products at affordable costs.

Stronger regulations on generics production, along with high costs of patent medications, have led to a boom in the Mexican generics market
Anne Engerant
View from the Top
Anne Engerant
Senior Vice President and General Manager LATAM Health
RB
Reckitt Benckiser participates in segments that include home care, hygiene and health.
Anne Engerant
View from the Top
Anne Engerant
Senior Vice President LATAM
RB* Health
RB® Health develops products for health and hygiene, including Clearasil, Dettol, Durex, Gaviscon, Mucinex, Nurofen, Scholl, Strepsils and Veet.
Subscribe to Anne Engerant